Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 501–600 of 898
Satoh, M., Sakuda, H., Kobayashi, T., Kataoka, T., Nakao, F., & Turale, S. (2007) · Nursing and Health Sciences · doi:10.1111/j.1442-2018.2007.00322.x · Cited by 12
Chronic Obstructive Pulmonary Disease in the Older Patient
Nazir, S. A., Alhamed, M., & Erbland, M. L. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.07.003 · Cited by 12
Wang, K., Wu, F., He, H., Hu, C., Chen, X.-D., Chen, J., Cao, W., Liu, J., Zhao, J., Zhao, Z., et al. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02955-5 · Cited by 11
Hu, C., Song, B., Liu, X., Sun, L., Li, M., & He, X. (2025) · International Journal of COPD · doi:10.2147/copd.s526194 · Cited by 11
Rott, C., Limen, E. F., Kriegsmann, K., Herth, F. J. F., & Brock, J. M. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107559 · Cited by 11
Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study
Papi, A. A., Magnoni, M. S., Muzzio, C. C., Benso, G., & Rizzi, A. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2016.721 · Cited by 11
Relation of Disease with Standardized Phase Angle Among Older Patients
Graf, C. E., Herrmann, F. R., & Genton, L. (2018) · The journal of nutrition health & aging · doi:10.1007/s12603-018-1034-4 · Cited by 11
Shimoda, M., Takao, S., Sugajima, Y., Tanaka, Y., Morimoto, K., Yoshida, N., Yoshimori, K., Ohta, K., & Senjyu, H. (2022) · Medicine · doi:10.1097/md.0000000000030704 · Cited by 11
[COPD and inflammation: statement from a French expert group. Phenotypes related to inflammation].
Pereza, T., Malb, H., Aguilaniuc, B., Brilletd, P.-Y., Chaouate, A., Louis, R., Muirg, J.-F., Similowskih, T., Berger, P., Burgel, P., et al. (2011) · Revue des maladies respiratoires · doi:10.1016/j.rmr.2010.08.011 · Cited by 6
Prognostic Factors in Chronic Obstructive Pulmonary Disease
Soler‐Cataluña, J. J., & Martínez‐García, M. Á. (2007) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(07)60155-4 · Cited by 11
Chan, H. P., Mukhopadhyay, A., Chong, P., Chin, S., Wong, X. Y., Ong, V., Chan, Y. H., Lim, T. K., & Phua, J. (2016) · Respirology · doi:10.1111/resp.12877 · Cited by 11
Marchioro, J. C., Gazzotti, M. R., Moreira, G. L., Manzano, B. M., Menezes, A. M. B., Pérez‐Padilla, R., Jardim, J. R., & Nascimento, O. A. (2019) · Jornal Brasileiro de Pneumologia · doi:10.1590/1806-3713/e20170157 · Cited by 11
Yuji, H., Yamagata, T., Honda, N., Ryuji, S., Sano, H., Iwanaga, T., Takayuki, M., Muraki, M., Tomita, K., Tohda, Y., et al. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00629.x · Cited by 11
Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE): Protocol and preliminary data
Gale, N., Albarrati, A., Munnery, M. M., Munnery, I., Irfan, M., Bolton, C. E., Rambaran, C., Tal‐Singer, R., Cockcroft, J. R., & Shale, D. J. (2014) · Chronic Respiratory Disease · doi:10.1177/1479972314546765 · Cited by 11
Sarcopaenia in chronic obstructive pulmonary disease
STEINER, M. C. (2007) · Thorax · doi:10.1136/thx.2006.067009 · Cited by 12
Lareau, S. C., ZuWallack, R., & Nici, L. L. (2025) · Life · doi:10.3390/life15050750 · Cited by 10
Metabolic Syndrome, Obesity Paradox and Testosterone Level
Emanuele, V. (2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000172 · Cited by 10
Murakami, Y., Yasui, H., Sato, J., Uto, T., Inui, N., Suda, T., & Imokawa, S. (2023) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666231172924 · Cited by 10
The impact of pulmonary cachexia on inpatient outcomes: A national study
Alahmad, M. A. M., & Gibson, C. (2023) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_31_23 · Cited by 10
Unintentional weight loss is reflected in worse one-year clinical outcomes among COPD outpatients
Yde, S. K., Mikkelsen, S. L., Brath, M. S. G., & Holst, M. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.09.012 · Cited by 10
Nutritional care in Chronic Obstructive Pulmonary Disease
Long, R., Stracy, C., & Oliver, M.-C. (2018) · British Journal of Community Nursing · doi:10.12968/bjcn.2018.23.sup7.s18 · Cited by 10
Barreiro, E., Sancho‐Muñoz, A., Puig‐Vilanova, E., Salazar‐Degracia, A., Pascual-Guàrdia, S., Casadevall, C., & Gea, J. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00611.2018 · Cited by 10
COPD patients' body composition and its impact on lung function.
Mjid, M., Snéne, H., Hédhli, A., Rouhou, S. C., Toujani, S., & Dhahri, B. (2021) · PubMed Central · Cited by 10
Han, Y., Wu, Z., Zhao, Q., Jiang, B., Miao, X., Lü, X., Qian, H., & Niu, M. (2022) · International Journal of COPD · doi:10.2147/copd.s373880 · Cited by 10
Farooqi, N., Slinde, F., Håglin, L., & Sandström, T. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0575-4 · Cited by 10
Parulekar, A. D., Wang, T., Li, G. W., Hoang, V., & Kao, C. C. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05373-5 · Cited by 10
Rehabilitation in chronic obstructive pulmonary disease
Troosters, T., Donner, C. F., Schols, A. M. W. J., & Decramer, M. (2006) · European Respiratory Society eBooks · doi:10.1183/1025448x.00038021 · Cited by 10
Self-citationRational monitoring of COPD: where do current clinical guidelines stand?
van den Bemt, L., Schermer, T. R., & van Weel, C. (2007) · European Respiratory Journal · doi:10.1183/09031936.00043107 · Cited by 10
Metabolic dysfunction-associated steatotic liver disease: an emerging comorbidity in COPD
Dailaty, A. A., Ghanem, A., Daher, G. A., Chaaban, T. A., & Chatila, R. (2025) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223251378868 · Cited by 9
Prognostication of co-morbidity clusters on hospitalisation and mortality in advanced COPD
James, B. D., Greening, N. J., Tracey, N., Haldar, P., Woltmann, G., Free, R. C., STEINER, M. C., Evans, R. A., & Ward, T. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2023.107525 · Cited by 9
Ramos, F. M. M., Rossato, L. T., Ramires, B. R., Pimentel, G. D., Venâncio, L. S., Orsatti, F. L., & de Oliveira, E. P. (2016) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2016.08.005 · Cited by 9
COMPARATIVE ANALYSIS OF DIFFERENT OBESITY DIAGNOSTIC METHODS: ANTROPOMETRY AND BODY IMPEDANCE
Filatova, O. V., Kutseva, E. V., & Burtseva, Y. S. (2018) · Экология человека · doi:10.33396/1728-0869-2018-9-48-51 · Cited by 9
Losartan does not inhibit cigarette smoke-induced lung inflammation in mice
Hepworth, M. L., Passey, S. L., Seow, H. J., & Vlahos, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-51504-2 · Cited by 9
Rutten, E. P. A., Bakke, P. S., Pillai, S. G., Wagers, S. S., Grydeland, T. B., Gulsvik, A., & Wouters, E. F. �. (2012) · Open Journal of Internal Medicine · doi:10.4236/ojim.2012.22019 · Cited by 9
Self-citationMkacher, W., Tabka, Z., & Trabelsi, Y. (2015) · Science & Sports · doi:10.1016/j.scispo.2015.11.001 · Cited by 9
Physical Therapy Effectiveness
Bernardo-Filho, M., de Sá-Caputo, D. D. C., & Taïar, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.76735 · Cited by 9
Arınç, S., Ağca, M., & Yaman, F. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-0663-y · Cited by 9
Annual Body Weight Change and Prognosis in Chronic Obstructive Pulmonary Disease
Abe, Y., Suzuki, M., Shima, H., Shiraishi, Y., Tanabe, N., Satô, S., Shimizu, K., Kimura, H., Makita, H., Hirai, T., et al. (2021) · International Journal of COPD · doi:10.2147/copd.s338908 · Cited by 9
Silander, E. M., Nyman, J., Bove, M., Johansson, L., Larsson, S., & Hammerlid, E. B. (2010) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2010.04.002 · Cited by 9
Gothi, D., Gupta, S. S., Kumar, N., & Sood, K. (2015) · Lung India · doi:10.4103/0970-2113.168132 · Cited by 9
Sami, R., Sadegh, R., Esmailzadehha, N., Mortazian, S., Nazem, M., & Zohal, M. A. (2018) · American Journal of Men s Health · doi:10.1177/1557988318760053 · Cited by 9
Voláková, E., Koblížek, V., Svoboda, M., Hejduk, K., Plutinský, M., Brat, K., Kulířová, M., & Zatloukal, J. (2025) · Biomedical Papers · doi:10.5507/bp.2025.001 · Cited by 8
Chen, W., Sadatsafavi, M., FitzGerald, J. M., Lynd, L. D., & Sin, D. D. (2021) · Respiratory Research · doi:10.1186/s12931-021-01656-5 · Cited by 8
Song, J. E., Bak, S. H., Lim, M.-N., Lee, E. J., Ki, Y., Yoon, H. J., & Kim, W. J. (2023) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2022.0152 · Cited by 8
Posthuma, R., van der Molen, M. C., Hartman, J. E., Spruit, M. A., Slebos, D., Vanfleteren, L. E. G. W., & Vaes, A. W. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107558 · Cited by 8
Gaynitdinova, V. V., & Avdeev, S. N. (2017) · PULMONOLOGIYA · doi:10.18093/0869-0189-2017-27-3-357-365 · Cited by 8
Khan, S., & Shahzadi, A. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1508226 · Cited by 8
Nutritional status and body composition among persons with chronic obstructive pulmonary disease
Odencrants, S., Ehnfors, M., & Ehrenberg, A. (2009) · Journal of Nursing and Healthcare of Chronic Illness · doi:10.1111/j.1365-2702.2008.01008.x · Cited by 8
Chan, H. P., Mukhopadhyay, A., Chong, P., Chin, S., Wong, X. Y., Ong, V., Chan, Y. H., Lim, T. K., & Phua, J. (2016) · International Journal of COPD · doi:10.2147/copd.s96790 · Cited by 8
Genkin, D., Jenkins, A. R., van Noord, N., Makimoto, K., Collins, S. É., Stickland, M. K., Tan, W. C., Bourbeau, J., Jensen, D., & Kirby, M. (2023) · ERJ Open Research · doi:10.1183/23120541.00485-2023 · Cited by 7
Diago, C. A. A., Ghadban, C., Calvo, J. A., Lavín, B. A., Martín-Audera, P., Guerra, A. R., Berja, A., Aranda, N., Guzun, A., Insua, A. I., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124154 · Cited by 7
Soins de support nutritionnels dans le parcours des patients atteints de cancers œsogastriques
Moura, A. D., Turpin, A., & Neuzillet, C. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2022.08.007 · Cited by 7
Harmouche, R., Ross, J. C., Washko, G. R., & Estépar, R. S. J. (2014) · Lecture notes in computer science · doi:10.1007/978-3-319-13972-2_4 · Cited by 7
Co-morbid disease in COPD--more than a coincidence.
Crockett, A. J., & Price, D. B. (2007) · PubMed Central · Cited by 7
Posłuszna, D., & Doboszyńska, A. (2011) · Advances in respiratory medicine · doi:10.5603/arm.27673 · Cited by 7
Budweiser, S., Jörres, R., Heinemann, F., & Pfeifer, R. (2009) · Pneumologie · doi:10.1055/s-0029-1214993 · Cited by 7
Stable State Proadrenomedullin Level in COPD Patients: A Validation Study
Zuur-Telgen, M. C., VanderValk, P. D. L. P. M., van der Palen, J. A. M., Kerstjens, H. A. M., & Brusse-Keizer, M. G. J. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2016.1250254 · Cited by 7
Place de l’éducation thérapeutique du patient atteint de BPCO en réhabilitation respiratoire
Ouksel, H. (2017) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2017.09.004 · Cited by 7
Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity!
Torrisi, S. E., Ley, B., Kreuter, M., Wijsenbeek, M. S., Vittinghoff, E., Collard, H. R., & Vancheri, C. (2019) · European Respiratory Journal · doi:10.1183/13993003.00615-2019 · Cited by 7
Osteoporosis in chronic obstructive pulmonary disease
Graat‐Verboom, L. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120316lg · Cited by 7
Odencrants, S. (2008) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 7
The Epidemiology of Combined Pulmonary Fibrosis and Emphysema among Mid-Atlantic Veterans
Guidot, D. M., Seaman, D. M., Pleasants, R. A., Boggan, J. C., Bedoya, A., Swaminathan, A. C., Maciejewski, M. L., Kaul, B., & Tighe, R. M. (2025) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202408-882oc · Cited by 6
Machado, F. V. C., Coninx, K., Neunhäeuserer, D., Tonoli, C., Niebauer, J., Piepoli, M. F., Pedretti, R. F. E., Kouidi, E. J., Ambrosetti, M., Dendale, P., et al. (2025) · Sports Medicine · doi:10.1007/s40279-025-02353-9 · Cited by 7
Diago, C. A. A., García‐Unzueta, M. T., Calvo, J. A., Martín-Audera, P., Fueyo, P. R., Lavín, B. A., Guerra, A. R., Muñoz, P., Tello, S., Berja, A., et al. (2022) · Pulmonology · doi:10.1016/j.pulmoe.2022.06.003 · Cited by 6
Kitahara, S., Abe, M., Kono, C., Sakuma, N., Ishii, D., Kawasaki, T., Ikari, J., & Suzuki, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-44138-y · Cited by 6
Advances in Chronic Obstructive Pulmonary Disease Imaging
Díaz, A. A., & Dolliver, W. R. (2020) · Barcelona Respiratory Network · doi:10.23866/brnrev:2019-0023 · Cited by 6
He, L., Li, Y., Gou, X., & Lei, L. (2023) · Medicine · doi:10.1097/md.0000000000033304 · Cited by 6
Clinical Impact of Time of Day on Acute Exercise Response in COPD
Chan-Thim, E., Dumont, M., Moullec, G., Rizk, A., Wardini, R., Trutschnigg, B., Paquet, J., de Lorimier, M., Parenteau, S., & Pepin, V. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2013.836167 · Cited by 6
Palliativmedizin in der Pneumologie
MAGNUSSEN, H., Heigener, D. F., Bausewein, C., Thomas, M. S., Eschbach, C., Schütte, W., Blankenburg, T., Steins, M. B., Bischoff, H., Schucher, B., et al. (2009) · Pneumologie · doi:10.1055/s-0029-1214538 · Cited by 6
„Nutritional Risk Screening 2002“ in der Hand des Pneumologen
Priegnitz, C., Galetke, W., Treml, M., & Randerath, W. (2014) · Pneumologie · doi:10.1055/s-0034-1365737 · Cited by 6
Peñailillo, L., Miranda‐Fuentes, C., Gutiérrez, S., García-Vicencio, S., Jannas-Vela, S., Acevedo, C. C., & Peñailillo, R. S. (2023) · Advances in experimental medicine and biology · doi:10.1007/5584_2023_784 · Cited by 5
Minter, M., van Odijk, J., Augustin, H., Machado, F. V. C., Franssen, F. M. E., Spruit, M. A., & Vanfleteren, L. E. G. W. (2024) · International Journal of COPD · doi:10.2147/copd.s458102 · Cited by 5
Impact of physical activity on respiratory diseases
Pawełczyk, W., & Rutkowski, S. (2025) · Slovak Journal of Sport Science · doi:10.24040/sjss.2024.9.2.94-114 · Cited by 5
Ximena Orellana, G., & I, L. M. (2011) · Revista chilena de enfermedades respiratorias · doi:10.4067/s0717-73482011000200010 · Cited by 5
The effects of a respiratory rehabilitation programme on body composition
Jipa, D., Croitoru, A., Bezdedeanu, A. E., Toma, C., & Bogdan, M. A. (2020) · Pneumologia · doi:10.2478/pneum-2020-0008 · Cited by 5
Alsharaway, L. A., Elyazed, T. I. A., & Helmy, N. A. (2021) · doi:10.56984/8zg209f33 · Cited by 5
van der Molen, M. C., Posthuma, R., Vaes, A. W., Spruit, M. A., Gosker, H. R., Viddeleer, A. R., Willems, T. P., Vanfleteren, L. E. G. W., Slebos, D., & Hartman, J. E. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.11.003 · Cited by 6
Caron, M., Thériault, M., Debigaré, R., & Maltais, F. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-673-3_9 · Cited by 5
Metabolic syndrome: contemporary views and danger in pregnancy
Давыдова, Ю. В., & Limanska, A. Y. (2019) · PERINATOLOGIYA I PEDIATRIYA · doi:10.15574/pp.2019.77.74 · Cited by 5
Study, C. C., Trompeter, G., Grigsby, M. R., Miele, C. H., Wise, R. A., Gilman, R. H., Miranda, J. J., Bernabé‐Ortiz, A., & Checkley, W. (2018) · Lung · doi:10.1007/s00408-018-0109-7 · Cited by 5
Assessment in pulmonary rehabilitation
Nyberg, A., Probst, V. S., & Vaes, A. W. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10017520 · Cited by 5
Nutrition et insuffisance respiratoire
Pison, C. M., Fontaine, E. M., Barnoud, D., & Cano, N. (2007) · Springer eBooks · doi:10.1007/978-2-287-33475-7_63 · Cited by 5
Évaluation de l'état nutritionnel du patient BPCO
Thibault, R., Veale, D., Chailleux, E., Darmaun, D., & Chambellan, A. (2006) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2006.10.180 · Cited by 5
Indicadores de disfagia na doença pulmonar obstrutiva crônica
Chaves, R. D. D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2010.tde-03092010-114120 · Cited by 5
Assessing the severity of COPD
Halpin, D. M. G. (2006) · Primary Care Respiratory Journal · doi:10.1016/j.pcrj.2005.12.005 · Cited by 5
Imashiro, K., Nakanishi, M., Minoshima, Y., Kouda, K., Sasaki, S., Takahashi, K., Asai, K., Hirano, T., Matsunaga, K., & Minakata, Y. (2025) · International Journal of COPD · doi:10.2147/copd.s513153 · Cited by 4
Chen, S., Ya, I.-L., Chen, P., Peng, H.-C., Liao, H.-Y., Yu, C., & Chien, J. (2025) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2024-002667 · Cited by 4
Griffiths, B., Al-Ajmi, R., Clifton, I., Birch, R. J., Peckham, D. G., & Price, O. J. (2026) · European Respiratory Review · doi:10.1183/16000617.0165-2025 · Cited by 4
Dysphagia of cachexia and sarcopenia
Matsuo, H., & Sakuma, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822146-4.00013-2 · Cited by 4
The importance of body composition assessment in the rehabilitation process
Murgoci, N. (2021) · Balneo and PRM Research Journal · doi:10.12680/balneo.2021.463 · Cited by 4
Khan, M. I., Khan, M. M. K. S., & Mannino, D. M. (2024) · European Respiratory Society eBooks · doi:10.1183/2312508x.10006323 · Cited by 4
Nutrition and Dietary Pattern Associated With Chronic Obstructive Pulmonary Disease
Tzeng, I., Su, W., Lee, Y.-K., & Wu, J. (2025) · eFood · doi:10.1002/efd2.70029 · Cited by 4
Naylor, R. J., & Piercy, R. J. (2015) · American Journal of Veterinary Research · doi:10.2460/ajvr.76.7.608 · Cited by 4
Sağlam, M., Savcı, S., Vardar‐Yağlı, N., Kutukcu, E. C., Arıkan, H., İnce, D. İ., Güçlü, M. B., Tunay, V. B., & Çöplü, L. (2013) · Türk fizyoterapi ve rehabilitasyon dergisi · doi:10.7603/s40680-013-0001-6 · Cited by 4
Evaluation of nutritional status and nutritional therapy in chronic obstructive pulmonary disease
Editorial, A. (2016) · PULMONOLOGIYA · doi:10.18093/0869-0189-2016-26-1-13-28 · Cited by 4
Association of Low body Mass Index with Respiratory Failure in Chronic Obstructive Pulmunary Disease
Oli, R., Mishra, J. K., Srivastava, G. N., & Mishra, S. K. (2021) · Journal of Nepal Health Research Council · doi:10.33314/jnhrc.v19i1.3372 · Cited by 4
Reizes, Z., McNamara, R. J., Dale, M., & McKeough, Z. J. (2023) · Physical Therapy · doi:10.1093/ptj/pzad064 · Cited by 4
Chewing ability and desaturation during chewing in patients with COPD
Terashima, T., Nakajima, T., Matsuzaki, T., Iwami, E., Shibui, T., Nomura, T., & Katakura, A. (2019) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2019.1090 · Cited by 4
Ardestani, M. E., Sajadi, G., & Jazayeri, N. (2016) · PubMed Central · Cited by 4
Ahmadi, A., Eftekhari, M. H., Mazloom, Z., Masoompour, M., Fararooei, M., Zare, M., & Hejazi, N. (2022) · Clinical Nutrition Research · doi:10.7762/cnr.2022.11.1.62 · Cited by 4
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.